Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.

Authors: Caudle, W Michael; Richardson, Jason R; Wang, Min Z; Taylor, Tonya N; Guillot, Thomas S; McCormack, Alison L; Colebrooke, Rebecca E; Di Monte, Donato A; Emson, Piers C; Miller, Gary W

Published In J Neurosci, (2007 Jul 25)

Abstract: The vesicular monoamine transporter 2 (VMAT2; SLC18A2) is responsible for packaging dopamine into vesicles for subsequent release and has been suggested to serve a neuroprotective role in the dopamine system. Here, we show that mice that express approximately 5% of normal VMAT2 (VMAT2 LO) display age-associated nigrostriatal dopamine dysfunction that ultimately results in neurodegeneration. Elevated cysteinyl adducts to L-DOPA and DOPAC are seen early and are followed by increased striatal protein carbonyl and 3-nitrotyrosine formation. These changes were associated with decreased striatal dopamine and decreased expression of the dopamine transporter and tyrosine hydroxylase. Furthermore, we observed an increase in alpha-synuclein immunoreactivity and accumulation and neurodegeneration in the substantia nigra pars compacta in aged VMAT2 LO mice. Thus, VMAT2 LO animals display nigrostriatal degeneration that begins in the terminal fields and progresses to eventual loss of the cell bodies, alpha-synuclein accumulation, and an L-DOPA responsive behavioral deficit, replicating many of the key aspects of Parkinson's disease. These data suggest that mishandling of dopamine via reduced VMAT2 expression is, in and of itself, sufficient to cause dopamine-mediated toxicity and neurodegeneration in the nigrostriatal dopamine system. In addition, the altered dopamine homeostasis resulting from reduced VMAT2 function may be conducive to pathogenic mechanisms induced by genetic or environmental factors thought to be involved in Parkinson's disease.

PubMed ID: 17652604 Exiting the NIEHS site

MeSH Terms: Animals; Dopamine/genetics; Dopamine/metabolism*; Dopamine/physiology; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neostriatum/metabolism*; Neostriatum/pathology; Nerve Degeneration/genetics; Nerve Degeneration/metabolism*; Nerve Degeneration/pathology; Substantia Nigra/metabolism*; Substantia Nigra/pathology; Synaptic Vesicles/genetics; Synaptic Vesicles/metabolism*; Vesicular Monoamine Transport Proteins/antagonists & inhibitors; Vesicular Monoamine Transport Proteins/genetics; Vesicular Monoamine Transport Proteins/metabolism*

Back
to Top